AARTIIND

Aarti Industries anticipates FY27 Capex to be in the range of INR 700-800 crore, a reduction from INR 1,125 crore in FY26, as part of capital allocation optimization. The company aims to reduce its net debt from INR 4,300 crore (3.6x Net Debt/EBITDA) at FY26 end to 2.5x Net Debt/EBITDA over the next two years, expecting a decline in FY27. Growth will be driven by two new long-term contracts signed in Q4 FY26 (one with INR 200-250 crore capex over 15 years, another $150 million multi-year supply agreement with no incremental capex). Zone IV projects, including a multipurpose plant and calcium chloride, are expected to be commissioned throughout FY27, with initial revenue from Q2 FY27, despite a 3-4 month delay due to labor constraints. The Augene JV is also on track for commissioning in H1FY27. Management expresses cautious optimism for FY27, emphasizing strong order visibility and strategic initiatives, but acknowledges near-term headwinds from geopolitical tensions in the Middle East, elevated freight rates, and rising raw material prices.

New Filing detected. See link for details.

Aarti Industries Limited's Board of Directors, in a meeting held on May 04, 2026, approved the re-appointment of Smt. Ketki D. Visariya as the Cost Auditor for the Financial Year FY2026-27. This re-appointment is for a term of one year, maintaining continuity in the company's cost audit function.

For the full year FY26, Aarti Industries reported Consolidated Revenue of ₹9,018 Cr versus ₹8,052 Cr (▲12% YoY), EBITDA of ₹1,172 Cr versus ₹1,019 Cr (▲15% YoY), and PAT of ₹419 Cr versus ₹330 Cr (▲27% YoY). The EBITDA Margin expanded to 13.0% versus 12.7% (▲34bps). The company also strengthened long-term growth with a backward integration initiative with ₹200-250 Cr capex for a 15-year contract and a $150 million multi-year supply agreement extending to March 2030.

For the quarter ended March 31, 2026, Aarti Industries Limited reported Consolidated Revenue of ₹2,205 Cr vs ₹1,952 Cr (▲13% YoY), EBITDA of ₹351 Cr vs ₹259 Cr (▲36% YoY), and PAT of ₹137 Cr vs ₹96 Cr (▲43% YoY). EBITDA Margin expanded from 13.3% to 15.9% (▲260bps). The Board also recommended a dividend of Re. 1/- per equity share for the financial year ended March 31, 2026.

Consolidated Revenue for Q4 FY26 was ₹2,206 Cr compared to ₹1,949 Cr in Q4 FY25 (▲13.2% YoY). EBITDA stood at ₹343 Cr versus ₹262 Cr (▲30.9% YoY), and PAT was ₹137 Cr against ₹96 Cr (▲42.7% YoY). The EBITDA Margin expanded from 13.4% to 15.6% (▲220bps). The Board also recommended a dividend of Re. 1/- (20%) per equity share of Face Value of Rs. 5/- for the Financial Year ended March 31, 2026.

Aarti Industries Limited's Board of Directors approved the grant of 2,80,700 stock options to eligible employees under the Performance Stock Option Plan 2022 on May 4, 2026. Each option has an exercise price of Rs. 5/- and will vest one-third annually over three years, subject to continued employment and achievement of performance conditions.